Qualifications & Awards
Academic Clinical Lectureship NIHR 2020
Travel Grant Guarantors of Brain 2020
Ivor Levy Prize United Kingdom Neuroophthalmology Society 2019
Best Abstract Award (resident) North American Neuroophthalmology Society 2019
Travel Grant ARVO Foundation 2019
Travel Grant Worshipful Company of Spectacle Makers 2019
Fellow Higher Education Academy 2019
Enhancing Learning and Teaching Certificate (Special commendation) The Oxford Learning Institute 2018
Wellcome Trust Clinical Research Training Fellowship 2016
Fellow Royal College of Ophthalmologists 2016
Clinical Academic Foundation Program University of Glasgow 2012
MB BChir University of Cambridge 2010
Sahara Essay Prize For scientific writing for a lay audience 2010
MA (Physiology, Development and Neuroscience) University of Cambridge 2007
Altounyan Fund Research Award, University of Cambridge 2007
Gridley Fund Research Award, University of Cambridge 2006
HE Durham Research Award, University of Cambridge 2006
Michael James Gilhooley
MA MB BChir DPhil FHEA FRCOphth
- NIHR Academic Clinical Lecturer, Institute of Ophthalmology, University College London
- Honorary Specialist Registrar, Moorfields Eye Hospital, London
- Honorary Specialist Registrar, The Royal Free Hospital, London
I completed my PhD under the supervision of Professors Hankins and Downes in 2019, funded by a Wellcome Trust Clinical Research Training Fellowship. Here I evaluated approaches to the deployment of therapeutic optogenetic tools in inherited retinal degenerations.
Prior to this, I studied Clinical Medicine at the University of Cambridge before undertaking an academic foundation program at the University of Glasgow. Following this, I joined the Moorfields / North Thames training scheme in surgical ophthalmology.
I have recently taken up an NIHR Academic Clinical Lectureship at the Institute of Ophthalmology, UCL, which will allow me to complete my clinical training part time while undertaking postdoctoral research. During this time, my research will focus on inherited optic neuropathies. I continue to collaborate closely with the retinal neurobiology & optogenetics group at the NLO, as well as the clinical ophthalmic research group at the Oxford Eye Hospital (ERGO).
Rhythmic expression of per1 in the dentate gyrus is suppressed by corticosterone: implications for neurogenesis.
Gilhooley MJ. et al, (2011), Neurosci Lett, 489, 177 - 181
Idiopathic Acquired Temporal Wedge Visual Field Defects
Gilhooley MJ. et al, (2016), Neuro-Ophthalmology, 40, 157 - 164
Artificial vision: Principles and prospects
Gilhooley MJ. and Acheson J., (2017), Current Opinion in Neurology, 30, 55 - 60
"Genetic and clinical findings in an ethnically diverse retinitis pigmentosa cohort associated with pathogenic variants in EYS".
Cundy O. et al, (2020), Eye (Lond)
The functional characteristics of optogenetic gene therapy for vision restoration
HANKINS M. et al, (2020), Cellular and Molecular Life Sciences
Expression and localization of Kcne2 in the vertebrate retina
HANKINS M. et al, (2020), Investigative Ophthalmology and Visual Science